Cytomegalovirus Infections
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated safety and immune response across different doses of a cytomegalovirus vaccine in healthy adults and ha…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
A completed clinical trial evaluating real-world monitoring of anti-CMV therapies in hematopoietic stem cell transplant recipients.
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®) [Phase 2]
Phase 2 trial assessing safety and immunogenicity of the MVA-based CMV vaccine Triplex has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis [Phase 4]
Phase 4 trial of topical 2% ganciclovir eye drops for CMV anterior uveitis and endotheliitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reporting completed results for Posoleucel (ALVR105) studied to prevent multiple viral infections after allogeneic hem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients. [Phase 3]
Phase 3 clinical trial evaluating reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients has compl…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: CMV-CTL for the Treatment of CMV Infection After HSCT [Phase 4]
Phase 4 clinical trial update for CMV-CTL as a treatment for cytomegalovirus infection after hematopoietic stem cell transplantation has com…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection [Phase 2]
A Phase 2 clinical trial update for letermovir in refractory or resistant Cytomegalovirus infection has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation [Phase 2]
Phase 2 trial comparing valganciclovir to valacyclovir for viral prophylaxis in kidney transplantation; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: Safety and Immunogenicity of the Human Cytomegalovirus (CMV) Vaccine (V160) in Healthy Japanese Men (V160-003) [Phase 1]
Phase 1 trial update on safety and immunogenicity of CMV vaccine V160 in healthy Japanese men completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002) [Phase 2]
Phase 2 trial update for V160 regimens in CMV-seronegative healthy females; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV [Phase 3]
Phase 3 trial investigating valganciclovir to prevent CMV organ damage in people with HIV has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-19Clinical Trial Update: Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection
A completed clinical trial evaluating PK/PD of ganciclovir in premature infants treated for CMV infection; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults [Phase 1]
Phase 1 study evaluating safety, tolerability, and immunogenicity of a human cytomegalovirus vaccine in healthy adults completed with result…
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation [Phase 3]
Phase 3 study assessing valganciclovir for CMV prophylaxis after renal transplantation has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection [Phase 1, Phase 2]
Preliminary clinical trial update on low-dose IL-2 and ganciclovir for cytomegalovirus infections (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus [NA]
Clinical trial completion update for a study on transmission of cytomegalovirus infection from mother to fetus; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Cytomegalovirus Infection in Patients With HIV-1 Infection [Phase 3]
Phase 3 clinical trial update for cytomegalovirus infection in patients with HIV-1 infection has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine [NA]
A completed clinical trial update evaluating the long-term persistence of GSK's cytomegalovirus vaccine candidate, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females [Phase 2]
A Phase 2 trial evaluating the gB/MF59 vaccine to prevent cytomegalovirus infection in healthy adolescent females has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients [Phase 2]
A Phase 2 study evaluating MCMV5322A/MCMV3068A for the prevention of Cytomegalovirus disease in high-risk kidney transplant recipients has c…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients [Phase 4]
A Phase 4 trial (VICTOR study) comparing oral valganciclovir (Valcyte) with intravenous ganciclovir in CMV disease among solid organ transpl…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Cytomegalovirus (CMV) Infection in Amniotic Fluid
Clinical trial update reporting a completed study on cytomegalovirus infection in amniotic fluid. Sponsored by the University of Pennsylvani…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Viral Activation Transfusion Study (VATS) [NA]
The Viral Activation Transfusion Study (VATS) sponsored by NHLBI has completed, investigating AIDS/HIV-related infections and cytomegaloviru…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients [Phase 4]
Phase 4 study evaluated valganciclovir dosing in pediatric solid organ transplant recipients to prevent CMV infection; results were posted i…